Respiratory Syncytial Virus (RSV)-Associated Hospitalizations and RSV-Associated Pediatric Deaths are Now Reportable Conditions in Wisconsin

Starting November 1, 2023 RSV-associated hospitalizations and RSV-associated pediatric deaths among Wisconsin residents are reportable to DHS. This change will bring RSV surveillance in alignment with influenza virus surveillance.

Vancomycin-Intermediate Staphylococcus aureus (VISA) and Vancomycin-Resistant Staphylococcus aureus (VRSA) as Reportable Conditions in Wisconsin

This memo provides updated guidance for reporting VISA/VRSA in Wisconsin: In alignment with current reporting guidelines for other multidrug-resistant organisms (MDROs), VISA/VRSA shall be considered a Category II reportable condition in Wisconsin.

Subscribe to

Glossary

 
Last revised June 30, 2025